youtube_live
Ganhos do Q2 2026 • em 4 dias
Ver detalheschevron_right
TWST:NASDAQ
Twist Bioscience Corp
US$ 58,45
arrow_upward
+3,09%(+1,75) 1D
US$ 58,00
arrow_downward
-0,77% (-0,45)bedtimeAfter-market
Fechado: 30 de abr., 16:00:00 GMT-4 · USD
search
Todos os símbolos
1D
5D
1M
6M
YTD
1A
5A
MÁX
| Códigos | Preço | Variação | % de variação |
|---|
insights_autoGerando os principais insights para TWST…
Abrir
US$ 57,50
Alta
US$ 60,60
Baixa
US$ 56,74
Valor de mercado
3,58 bi
Volume médio
1,18 mi
Volume
1,55 mi
Alto — 52 sem
US$ 65,10
Baixo — 52 sem
US$ 23,30
LPA
-US$ 1,27
Beta
2,21
Ações em circulação
61,31 mi
Nº de funcionários
979
Notícias
De fontes em toda a Web
Stock Titan
·
há 6 horas
ARK Investment Management reports 10.35% stake in Twist Bioscience (NASDAQ: TWST)
Perfil
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
Sobre Twist Bioscience Corp
O conteúdo gerado com IA pode ter erros. Saiba mais